SCOPUS 정보 검색 플랫폼

Clinical Cancer Research

Volumn 15, Issue 19, 2009, Pages 5945-5946

Inhibiting the hypoxia response for cancer therapy: The new kid on the block

(3) Mei, Yee Koh a Spivak Kroizman, Taly R a Powis, Garth a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [BIS(2 CHLOROETHYL)OXIDOAMINO]PHENYLALANINE; ANTINEOPLASTIC AGENT; CARBONATE DEHYDRATASE IX; ENDOTHELIN 1; ENOLASE; ENOLASE 1; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KC7F2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER THERAPY; CELL PROLIFERATION; CLINICAL TRIAL; CYTOTOXICITY; HUMAN; HYPOXIA; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; DISULFIDES; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; NEOPLASMS; SULFONAMIDES;

EID: 70349673606 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: 10.1158/1078-0432.CCR-09-1650 Document Type: Note

Times cited : (25)

References (8)

1
- 70349696534
- Identification of a novel small molecule HIF-1á translation inhibitor
- Narita T, Yin S, Gelin C, et al. Identification of a novel small molecule HIF-1á translation inhibitor. Clin Cancer Res 2009;15:6128-6136
- (2009) Clin Cancer Res , vol.15 , pp. 6128-6136
- Narita, T.¹ Yin, S.² Gelin, C.³

2
- 19944431335
- Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway
- Tan C, de Noronha RG, Roecker AJ, et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 2005;65:605-612
- (2005) Cancer Res , vol.65 , pp. 605-612
- Tan, C.¹ De Noronha, R.G.² Roecker, A.J.³

3
- 34547124062
- Hypoxia: A key regulator of angiogenesis in cancer
- Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007;26:281-290
- (2007) Cancer Metastasis Rev , vol.26 , pp. 281-290
- Liao, D.¹ Johnson, R.S.²

4
- 4944229705
- Schedule-dependent inhibition of hypoxia-inducible factor-1á protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
- DOI 10.1158/0008-5472.CAN-04-2116
- Rapisarda A, Zalek J, Hollingshead M, et al. Schedule-dependent inhibition of hypoxia-inducible factor-1á protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer Res 2004;64:6845-6848 (Pubitemid 39330988)
- (2004) Cancer Research , vol.64 , Issue.19 , pp. 6845-6848
- Rapisarda, A.¹ Zalek, J.² Hollingshead, M.³ Braunschweig, T.⁴ Uranchimeg, B.⁵ Bonomi, C.A.⁶ Borgel, S.D.⁷ Carter, J.P.⁸ Hewitt, S.M.⁹ Shoemaker, R.H.¹⁰ Melillo, G.¹¹

5
- 57749106966
- A novel mode of action of YC-1 in HIF inhibition: Stimulation of FIH-dependent p300 dissociation from HIF-1á
- PubMed doi:10.1158/1535-7163.MCT-08-0074
- Li SH, Shin DH, Chun YS, Lee MK, Kim MS, Park JW. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1á. Mol Cancer Ther 2008;7:3729-3738 PubMed doi:10.1158/1535-7163. MCT-08-0074.
- (2008) Mol Cancer Ther , vol.7 , pp. 3729-3738
- Li, S.H.¹ Shin, D.H.² Chun, Y.S.³ Lee, M.K.⁴ Kim, M.S.⁵ Park, J.W.⁶

6
- 38349092288
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1á
- PubMed doi:10.1158/1535-7163.MCT-07-0463
- Koh MY, Spivak-Kroizman T, Venturini S, et al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1á. Mol Cancer Ther 2008;7:90-100. PubMed doi:10.1158/1535-7163. MCT-07-0463.
- (2008) Mol Cancer Ther , vol.7 , pp. 90-100
- Koh, M.Y.¹ Spivak-Kroizman, T.² Venturini, S.³

7
- 0142144338
- The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1á and vascular endothelial growth factor formation
- Welsh SJ, Williams RR, Birmingham A, Newman DJ, Kirkpatrick DL, Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1á and vascular endothelial growth factor formation. Mol Cancer Ther 2003;2:235-243
- (2003) Mol Cancer Ther , vol.2 , pp. 235-243
- Welsh, S.J.¹ Williams, R.R.² Birmingham, A.³ Newman, D.J.⁴ Kirkpatrick, D.L.⁵ Powis, G.⁶

8
- 52149083002
- Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival
- Barnhart BC, Lam JC, Young RM, Houghton PJ, Keith B, Simon MC. Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival. Cancer Biol Ther 2008;7:1441-1449
- (2008) Cancer Biol Ther , vol.7 , pp. 1441-1449
- Barnhart, B.C.¹ Lam, J.C.² Young, R.M.³ Houghton, P.J.⁴ Keith, B.⁵ Simon, M.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.